EBV Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of EBV monoclonal antibodies for the detection and analysis of Epstein-Barr Virus proteins. EBV Antibodies are compatible with various research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Epstein-Barr Virus is a member of the herpesvirus family and is known for its role in infectious mononucleosis and its association with several malignancies, including Burkitt lymphoma and Hodgkin's lymphoma. Understanding EBV protein function is crucial for elucidating the mechanisms of viral pathogenesis and the immune response. The study of EBV is significant for developing therapeutic strategies and vaccines against EBV-related diseases. Research into EBV proteins continues to reveal new insights about viral infection mechanisms and host immune responses. Investigating EBV protein interactions helps identify potential therapeutic targets for treating associated diseases. Current research focuses on understanding how EBV proteins contribute to viral persistence and oncogenesis. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of EBV and its impact on human health.